Low levels of sugar to prevent cardiovascular disease Background Cardiovascular disease (CVD) is a group of disorders affecting the heart and blood vessels and the number one cause of death worldwide. It is important to detect modifiable risk factors and find strategies to prevent CVD. There are several established modifiable risk factors for developing CVD, one of them being eating an unhealthy diet rich in sugar. Sugar can be divided in two categories; sugars naturally occurring in food and sugars that are added to food. A high level of added sugar intake is suggested to cause weight gain...

What are the benefits and risks of percutaneous blood clot removal (thrombectomy) and dissolution of blood clot accelerated by ultrasound waves (ultrasound-accelerated thrombolysis) for treating acute limb ischaemia? Key messages Because of a lack of robust evidence, the benefits and risks of percutaneous blood clot removal (the removal of a blood clot via a needle puncture in the skin, known as percutaneous thrombectomy) or ultrasound-accelerated thrombolysis (where ultrasound waves are sent by a specific device into the blood vessel to accelerate the dissolution of a blood clot) for the...

The combination of transcatheter arterial chemoembolisation and thermal ablation versus TACE alone for hepatocellular carcinoma Background Hepatocellular carcinoma (a common kind of liver cancer) is the sixth most common cancer in the world. Transcatheter arterial chemoembolisation (TACE) (injecting agents into the feeding vessels of the tumour to reduce the blood supply to the tumour and kill the tumour) is the most common therapy for hepatocellular carcinoma, but the clinical outcome is poor. In recent years, the combination of TACE plus thermal ablation (killing the tumour cell by...

Thermal stability and storage of human insulin This is a protocol for a Cochrane Review (prototype). The objectives are as follows: To analyse the effects of storing human insulin above or below the manufacturers' recommended insulin temperature storage range or advised usage time, or both, after dispensing human insulin to people with diabetes. This is a protocol....